Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from first-line immunotherapy in NSCLC

Abstract Background Many studies have compared real-world clinical outcomes of immunotherapy in patients with metastatic non-small cell lung cancer (NSCLC) with reported outcomes data from pivotal trials. However, any differences observed could be only limitedly explored further for causation becaus...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	R. K. Ismail, F. M. N. H. Schramel, M. van Dartel, A. M. G. Pasmooij, C. M. Cramer-van der Welle, D. L. Hilarius, A. de Boer, M. W. J. M. Wouters, E. M. W. van de Garde
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2023-01-01
Saila:	BMC Medical Research Methodology
Gaiak:	NSCLC Nivolumab Real-world Efficacy- effectiveness gap
Sarrera elektronikoa:	https://doi.org/10.1186/s12874-022-01760-0
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!